[HTML][HTML] Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
AO Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu… - Cell Death & …, 2021 - nature.com
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation.
A Chen, Z Chen, Y Zhou, Y Wu, Y Xia… - Cell Death & …, 2021 - search.ebscohost.com
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
A Chen, Z Chen, Y Zhou, Y Wu, Y Xia… - Cell death & …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …
[HTML][HTML] Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
A Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu… - Cell Death & …, 2021 - ncbi.nlm.nih.gov
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation.
A Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu… - Cell Death & …, 2021 - europepmc.org
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
A Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu, M Fan… - Cell Death & …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Coronary microembolization (CME), a common
reason for periprocedural myocardial infarction (PMI), bears very important prognostic …
reason for periprocedural myocardial infarction (PMI), bears very important prognostic …
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
A Chen, C Zhangwei, Y Zhou, Y Wu, Y Xia… - Cell Death and …, 2021 - search.proquest.com
Coronary microembolization (CME), a common reason for periprocedural myocardial
infarction (PMI), bears very important prognostic implications. However, the molecular …
infarction (PMI), bears very important prognostic implications. However, the molecular …